Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Truncating Titin (TTN) Variants in Chemotherapy-Induced Cardiomyopathy.

Journal of cardiac failure - 1 Jun 2017

Linschoten M, Teske A J, Baas A F, Vink A, Dooijes D, Baars H F, Asselbergs F W

Abstract excerpt

Chemotherapy-induced cardiomyopathy (CCMP) is a complication of chemotherapy treatment occurring in 9% of patients treated with the use of anthracyclines. Currently, risk stratification is based on clinical risk factors that do not adequately account for variable individual susceptibility. This suggests the presence of other determinants. In this case series, we describe 2 women with breast cancer who developed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Breast Neoplasms
Share to Carcinoma, Ductal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiomyopathies

Share to Connectin

Share to Fatal Outcome

Share to TTN gene

Share to Genetic Variation

Source

Identifiers

PMID: 28315399
DOI: 10.1016/j.cardfail.2017.03.003

Genes

TTN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Truncating Titin (TTN) Variants in Chemotherapy-Induced Cardiomyopathy.PMID 28315399Read ↗

Genetic predisposition in chemotherapy-induced cardiomyopathy in a 65-year-old female with metastatic breast cancer.Semantic proximity Read ↗

Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy.Semantic proximity Read ↗

Titin Truncating Variants in Dilated Cardiomyopathy - Prevalence and Genotype-Phenotype Correlations.Semantic proximity Read ↗

Titin-Truncating Variants Increase the Risk of Cardiovascular Death in Patients With Hypertrophic Cardiomyopathy.Semantic proximity Read ↗

Prognostic implications of pathogenic truncating variants in the TTN gene.Semantic proximity Read ↗

The genetic underpinnings of anthracycline-induced cardiomyopathy predisposition.Semantic proximity Read ↗

Chemotherapy-Related Cardiac Dysfunction: A Systematic Review of Genetic Variants Modulating Individual Risk.Semantic proximity Read ↗

Familial Frequent Premature Ventricular Contractions and the Relevance of Titin Mutations.Semantic proximity Read ↗

The incidence of cardiomyopathy in BRCA1 and BRCA2 mutation carriers after anthracycline-based adjuvant chemotherapy.Semantic proximity Read ↗

Breast Cancer Clinical Trial of Chemotherapy and Trastuzumab: Potential Tool to Identify Cardiac Modifying Variants of Dilated CardiomyopathySemantic proximity Read ↗

Mechanisms and Genetic Susceptibility of Chemotherapy-Induced Cardiotoxicity in Patients With Breast Cancer.Semantic proximity Read ↗

CELF4 Variant and Anthracycline-Related Cardiomyopathy: A Children's Oncology Group Genome-Wide Association Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.